Press release
Progressive Supranuclear Palsy - Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments
Progressive Supranuclear Palsy
Download PDF Sample Pages to Get an in-depth Assessment of the Emerging Therapies and Key Companies:https://www.globalinsightservices.com/request-sample/GIS31301
Progressive Supranuclear Palsy is a rare neurodegenerative disease that leads to difficulty with balance, movement, vision, speech, and swallowing. Progressive supranuclear palsy typically begins in late middle age and worsens over time, with severe disability occurring within three to five years of onset. The disease can lead to serious complications such as pneumonia, choking, head injuries, and fractures.
Progressive supranuclear palsy is primarily caused by the accumulation of a protein called tau, as well as ageing and mitochondrial dysfunction, which is also a factor in progressive supranuclear palsy, particularly mitochondrial complex I inhibitors.
Report Highlights
Global Insight Service's, "Progressive Supranuclear Palsy - Drug Pipeline Landscape, 2023," an overview of the progressive supranuclear palsy pipeline drugs. This report covers detailed insights on progressive supranuclear palsy drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to gain insights and thus help industry participants for decision making. Progressive supranuclear palsy pipeline report helps gaining insights on drugs which are under development stage of drug development process across globally. Global Insight Services aims to cover all the drug attributes, deals, regulatory milestones and all the upcoming milestones.
Recent Developments
In February 2023, Ferrer acquired worldwide rights from Asceneuron, which signed a licence agreement to develop and commercialise ASN90 on the PSP.
In June 2021, Pinteon extended collaboration with Lonza for manufacturing PNT001.
In July 2016, NeuroTau Inc received orphan drug designation from US FDA for Tolfenamic acid (NTX-010) for the treatment of progressive supranuclear palsy.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources carried out to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, clinical trials registries.
Scope
The pipeline landscape report consists of pipeline product based on several stages of development ranging from discovery to Pre-Registration. The report provides a review of pipeline therapeutics for progressive supranuclear palsy by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of progressive supranuclear palsy therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals and key upcoming milestones.
For In-Depth Competitive Analysis, Purchase this Report : https://www.globalinsightservices.com/checkout/single_user/GIS31301
Report Covers the Emerging Pipeline Products Under Different Phases of Clinical Development Like -
- Late-stage products (Phase III)
- Mid-stage products (Phase II)
- Early-stage product (Phase I)
- Pre-clinical and Discovery stage candidates
- Discontinued & Inactive candidates
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Progressive Supranuclear Palsy - Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments here
News-ID: 2951447 • Views: …
More Releases from Global Insight Services
Hydrogen Generation Market Poised to Grow from $155.5 Billion in 2024 to $410.6 …
The Hydrogen Generation Market is set to experience remarkable growth, expanding from $155.5 billion in 2024 to an estimated $410.6 billion by 2034, registering a robust CAGR of approximately 10.2%. Hydrogen generation involves producing and supplying hydrogen through various techniques, including steam methane reforming, electrolysis, and coal gasification. This market plays a pivotal role in supporting industries seeking cleaner energy solutions, spanning transportation, power generation, and industrial processes. As the…
Identity and Access Management Market Poised to Grow from $15.9 Billion in 2024 …
The Identity & Access Management (IAM) market is poised for substantial growth, expanding from an estimated $15.9 billion in 2024 to $38.2 billion by 2034 at a robust CAGR of approximately 9.2%. IAM encompasses systems, tools, and policies that manage digital identities and regulate user access within organizations. This includes solutions such as authentication, single sign-on, identity governance, and privileged access management. These technologies are essential for ensuring security, compliance,…
Endoscopy Devices Market Is Anticipated To Expand From $14.5 Billion In 2024 To …
Market Overview
The Endoscopy Devices Market is playing an increasingly important role in modern healthcare by supporting minimally invasive diagnostic and surgical procedures. These devices, which include endoscopes, visualization systems, and complementary instruments, allow physicians to examine internal organs with precision, leading to faster diagnoses, less trauma for patients, and improved recovery times. As the global burden of chronic diseases rises, the demand for such technologies continues to expand. Additionally, advancements…
Sustainable Fashion Market Is Anticipated To Expand From $13.8 Billion In 2024 T …
Market Overview
The Sustainable Fashion Market has gained remarkable momentum in recent years as consumers, brands, and policymakers increasingly recognize the need for eco-friendly and socially responsible alternatives in the fashion industry. Unlike conventional fashion, which is often criticized for its high carbon footprint and exploitative labor practices, sustainable fashion emphasizes the use of organic, recycled, and biodegradable materials, along with ethical supply chains and fair trade principles. This shift represents…
More Releases for Progressive
Progressive Insurance Market Is Booming So Rapidly | Major Giants Progressive Co …
HTF MI just released the Global Progressive Insurance Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Key Players in This Report Include:
Progressive Corporation, State Farm, Allstate, GEICO,…
Progressive Multifocal Leukoencephalopathy Treatment Global Market Report 2024 - …
"The progressive multifocal leukoencephalopathy treatment market size has grown rapidly in recent years. It will grow from $1.31 billion in 2023 to $1.46 billion in 2024 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to prevalence of underlying conditions, rise in immunosuppressed patients, patient advocacy and awareness, rise of hiv/aids epidemic.
The progressive multifocal leukoencephalopathy treatment market size is…
Progressive Multifocal Leukoencephalopathy Treatment Market Size 2034
DelveInsight's 'Progressive Multifocal Leukoencephalopathy Market Insights, Epidemiology, and Market Forecast - 2034' report deliver an in-depth understanding of the historical and forecasted epidemiology as well as the market trends of Progressive Multifocal Leukoencephalopathy in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
Key Takeaways from the Progressive Multifocal Leukoencephalopathy Market Report
• According to DelveInsight's analysis, the incident cases of PML in the 7MM were approximately 4…
Seminar on Progressive Farming
Shri Venkateshwara University/VGI Meerut in collaboration with Bhartiya Kisan Union (Meerut Division) is organizing a 1 day seminar on Progressive farming & farmer the foundation of development on Nov 3rd.In this seminar, the National Organization Minister of All India Farmer's Organization Mr Dinesh Kulkarni, Padamshree Mr Bharat Bhushan Tyagi, & the State Agriculture Minister Mr Baldev Singh Aulakh will take part.Apart from these renowned agriculture scientists, environmentalists, bureaucrats & 400…
Progressive Supranuclear Palsy Headed Toward Cure
Progressive supranuclear palsy (PSP) is a brain disorder which impacts vision, cognition, movement, and speech. This disease results in weakness by affecting certain parts of the brain above the cell clusters, known as nuclei (supranuclear), which are involved in controlling eye movements. It usually manifests in mid-to late adulthood, and the survival rate of people suffering from PSP is five to nine years after the disease first appears. It is…
Progressive Personnel rebrands to Progressive Travel Recruitment
Global travel and hospitality recruitment leader, Progressive Personnel, this month re-emerges as Progressive Travel Recruitment with a fresh new look and a new website under the new URL – www.progressivetravelrecruitment.com – with enhanced job search capability.
Progressive Travel Recruitment’s competitive edge, however, remains – a dedicated team of specialist travel recruiters, who have themselves worked in the industry and understand intimately the needs of travel companies and travel candidates, and…
